Cl. Mackall et al., AGE, THYMOPOIESIS, AND CD4-LYMPHOCYTE REGENERATION AFTER INTENSIVE CHEMOTHERAPY( T), The New England journal of medicine, 332(3), 1995, pp. 143-149
Background. Inadequate reconstitution of CD4+ T lymphocytes is an impo
rtant clinical problem complicating chemotherapy, human immunodeficien
cy virus infection, and bone marrow transplantation, but relatively li
ttle is known about how CD4+ T lymphocytes regenerate. There are two m
ain possibilities: bone marrow-derived progenitors could reconstitute
the lymphocyte population using a thymus-dependent pathway, or thymus-
independent pathways could predominate. Previous studies have suggeste
d that the CD45RA glycoprotein on CD4+ T lymphocytes is a marker for p
rogeny generated by a thymus-dependent pathway. Methods. We studied 15
patients 1 to 24 years of age who had undergone intensive chemotherap
y for cancer. The absolute numbers of CD4+ T lymphocytes in peripheral
blood and the expression of CD45 isoforms (CD45RA and CD45RO) on thes
e lymphocytes were studied serially during lymphocyte regeneration aft
er the completion of therapy. Radiographic imaging of the thymus was p
erformed concomitantly. Results. There was an inverse relation between
the patients' ages and the CD4+ T-lymphocyte counts six months after
therapy was completed (r=-0.92). The CD4+ recovery correlated quantita
tively with the appearance of CD45RA+CD4+ T lymphocytes in the blood (
r=0.64). There was a higher proportion of CD45RA+CD4+ T lymphocytes in
patients with thymic enlargement after chemotherapy than in patients
without such enlargement (two-sided P=0.015). Conclusions. Thymus-depe
ndent regeneration of CD4+ T lymphocytes occurs primarily in children,
whereas even young adults have deficiencies in this pathway. Our resu
lts suggest that rapid T-cell regeneration requires residual thymic fu
nction in patients receiving high-dose chemotherapy.